Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2020 16:02 ET | Source: Aptose Biosciences, Inc.

Aptose Reports Results for the Fourth Quarter and Full Year 2019

SAN DIEGO and TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated...
February 25, 2020 07:31 ET | Source: Aptose Biosciences, Inc.

Aptose to Release Fourth Quarter and Year End December 31, 2019 Financial Results and Hold Conference Call on March 10, 2020

SAN DIEGO and TORONTO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
January 29, 2020 07:30 ET | Source: Aptose Biosciences, Inc.

Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor Conference

SAN DIEGO and TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
January 07, 2020 07:30 ET | Source: Aptose Biosciences, Inc.

Aptose Biosciences to Present at Biotech Showcase™ 2020 Conference

SAN DIEGO and TORONTO, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
December 19, 2019 16:02 ET | Source: Aptose Biosciences, Inc.

Aptose Announces Closing of Public Offering of Common Shares

SAN DIEGO and TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced the closing of its previously announced...
December 17, 2019 08:00 ET | Source: Aptose Biosciences, Inc.

Aptose Announces Pricing of Public Offering of Common Shares

SAN DIEGO and TORONTO, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it priced its previously announced...
December 16, 2019 16:19 ET | Source: Aptose Biosciences, Inc.

Aptose Announces Proposed Public Offering of Common Shares

SAN DIEGO and TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it has commenced an underwritten public...
December 09, 2019 11:00 ET | Source: Aptose Biosciences, Inc.

Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting

SAN DIEGO and TORONTO, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting...
December 07, 2019 11:00 ET | Source: Aptose Biosciences, Inc.

Aptose Presents Highlights From Corporate Event At ASH

SAN DIEGO, TORONTO and ORLANDO, Fla., Dec. 07, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) released highlights from a corporate event and clinical update today held at...
December 04, 2019 07:30 ET | Source: Aptose Biosciences, Inc.

Aptose Appoints Rafael Bejar, M.D., Ph.D., as Chief Medical Officer

SAN DIEGO and TORONTO, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the...